Adverse events generated by acellular dermal matrix in treatment of diabetic foot ulcers: A Literature Review

María Carolina Torres Díaz, Luisa María Picón Tamayo, Gilma Jeannette Caraballo Martínez, Julieth Yadira Serrano Riaño, Juan Jairo Vaca-González

Texto completo:

PDF (English)


Background: The purpose of this review was to highlight the acquired complications when acellular dermal matrix is grafted in chronic diabetic foot ulcers.

Methods: Different information sources, Pubmed, Research and Scielo databases were reviewed to summarize different contributions for the past 20 years.

Results: Adverse events reported by application of acellular dermal matrix were infection, seroma, peri-wound erythema, maceration, hematomas, liquefactions, necrosis, gastrointestinal disorder, ischemia, malodor and matrix resorption.

Conclusions: The acellular dermal matrix as dermal substitute generates adverse events when treating diabetic foot ulcers; however, there are optimal allografts that did not register adverse events after application. Regardless the adverse events generate by acellular dermal matrix, they may improve the healing process of uninfected, non-ischemic and full-thickness diabetic foot ulcers. In fact, it is evident that the acellular dermal matrix has advantages compared with standard of care.

Palabras clave

Diabetic foot ulcer; Acellular dermal matrix; Adverse events; Diabetes.


Prieto-Gómez B, Aguirre-Castañeda A, Saldaña-Lorenzo J, León del Ángel J, Moya-Simarro A. Síndrome metabólico y sus complicaciones: el pie diabético [Internet]. Vol. 60, Revista de la Facultad de Medicina de la UNAM. scielomx; 2017. p. 7–18. Available from:

Parvizi J, Kim G. Diabetic Foot. In: Parvizi J, Kim GKBT-HYO, editors. High Yield Orthopaedics [Internet]. Philadelphia: W.B. Saunders; 2010. p. 141–2. Available from:

Couselo-Fernández I, Rumbo-Prieto J. Riesgo de pie diabético y déficit de autocuidados en pacientes con Diabetes Mellitus Tipo 2 [Internet]. Vol. 15, Enfermería universitaria. scielomx; 2018. p. 17–29. Available from:

Mavrogenis A, Megaloikonomos P, Antoniadou T, Igoumenou V, Panagopoulos G, Dimopoulos L, et al. Current concepts for the evaluation and management of diabetic foot ulcers. EFORT open Rev [Internet]. 2018 Sep 27;3(9):513–25. Available from:

Gordon K, Lebrun E, Tomic-Canic M, Kirsner R. The role of surgical debridement in healing of diabetic foot ulcers. Wound Repair Regen [Internet]. 2010 Sep 1;18(5):433–8. Available from:

Nain P, Uppal S, Garg R, Bajaj K, Garg S. Role of negative pressure wound therapy in healing of diabetic foot ulcers. J Surg Tech Case Rep [Internet]. 2011 Jan;3(1):17–22. Available from:

Izadi M, Kheirjou R, Mohammadpour R, Aliyoldashi M, Moghadam S, Khorvash F, et al. Efficacy of comprehensive ozone therapy in diabetic foot ulcer healing. Diabetes Metab Syndr Clin Res Rev [Internet]. 2019;13(1):822–5. Available from:

Guo X, Mu D, Gao F. Efficacy and safety of acellular dermal matrix in diabetic foot ulcer treatment: A systematic review and meta-analysis. Int J Surg [Internet]. 2017;40:1–7. Available from:

Orgill D, Gobble R. Skin Regeneration and Bioengineering. In: Orlando G, Lerut J, Soker S, Stratta RJBT-RMA in OT, editors. Regenerative Medicine Applications in Organ Transplantation [Internet]. Boston: Academic Press; 2014. p. 761–70. Available from:

Medina C, Castillo M. Aplicación clínica de la Matriz Dérmica Acelular para coberturas radiculares - Revisión de literatura. Acta Odontológica Venez [Internet]. 2014;52(4):1–10. Available from:

Kavros S, Dutra T, Gonzalez-Cruz R, Liden B, Marcus B, McGuire J, et al. The Use of PriMatrix, a Fetal Bovine Acellular Dermal Matrix, in Healing Chronic Diabetic Foot Ulcers: A Prospective Multicenter Study. Adv Ski Wound Care [Internet]. 2014;27(8):356–62. Available from:

Walters J, Cazzell S, Pham H, Vayser D, Reyzelman A. Healing Rates in a Multicenter Assessment of a Sterile, Room Temperature, Acellular Dermal Matrix Versus Conventional Care Wound Management and an Active Comparator in the Treatment of Full-Thickness Diabetic Foot Ulcers. Eplasty [Internet]. 2016 Feb 4;16:73–86. Available from:

Cervelli V, Lucarini L, Cerretani C, Spallone D, Palla L, Brinci L, et al. The use of Matriderm® and autologous skin grafting in the treatment of diabetic ulcers: a case report. Int Wound J [Internet]. 2010 Aug 1;7(4):291–6. Available from:

Campitiello F, Mancone M, Della Corte A, Guerniero R, Canonico S. To evaluate the efficacy of an acellular Flowable matrix in comparison with a wet dressing for the treatment of patients with diabetic foot ulcers: a randomized clinical trial. Updates Surg [Internet]. 2017;69(4):523–9. Available from:

Brown-Etris M, Milne C, Hodde J. An extracellular matrix graft (Oasis® wound matrix) for treating full-thickness pressure ulcers: A randomized clinical trial. J Tissue Viability [Internet]. 2019;28(1):21–6. Available from:

Stacey D. Use of an acellular regenerative tissue matrix over chronic wounds. Eplasty [Internet]. 2013 Nov 20;13(61):514–21. Available from:

Varkey M, Ding J, Tredget E. Advances in Skin Substitutes-Potential of Tissue Engineered Skin for Facilitating Anti-Fibrotic Healing. J Funct Biomater [Internet]. 2015 Jul 9;6(3):547–63. Available from:

Campitiello F, Della Corte A, Guerniero R, Pellino G, Canonico S. Efficacy of a New Flowable Wound Matrix in Tunneled and Cavity Ulcers: A Preliminary Report. Wounds [Internet]. 2015;27(6):152–7. Available from:

Yao M, Attalla K, Ren Y, French M, Driver V. Ease of Use, Safety, and Efficacy of Integra Bilayer Wound Matrix in the Treatment of Diabetic Foot Ulcers in an Outpatient Clinical Setting: A Prospective Pilot Study. J Am Podiatr Med Assoc [Internet]. 2013 Jul 1;103(4):274–80. Available from:

Rennert R, Sorkin M, Garg R, Januszyk M, Gurtner G. Cellular Response to a Novel Fetal Acellular Collagen Matrix: Implications for Tissue Regeneration. Chirila T V, editor. Int J Biomater [Internet]. 2013;1–9. Available from:

Bingham M. Timely News and Notes for Primary Care Providers From The American Diabetes Association. Clin Diabetes [Internet]. 2018 Apr;36(2):92–6. Available from:

Jeon H, Kim J, Yeo H, Jeong H, Son D, Han K. Treatment of diabetic foot ulcer using matriderm in comparison with a skin graft. Arch Plast Surg [Internet]. 2013/07/17. 2013 Jul;40(4):403–8. Available from:

Zelen C, Orgill D, Serena T, Galiano R, Carter M, DiDomenico L, et al. Human Reticular Acellular Dermal Matrix in the Healing of Chronic Diabetic Foot Ulcerations that Failed Standard Conservative Treatment: A Retrospective Crossover Study. Wounds [Internet]. 2017;29(2):39–45. Available from:

Bingol U, Cinar C, Arslan H, Altındas M. A Novel and Alternative Treatment Method for Diabetic Heel Ulceration Exposing the Calcaneus Which Is Not Suitable for Flap Surgery: Vacuum Assisted Sandwich Dermal Matrix. Piérard GE, editor. Biomed Res Int [Internet]. 2015;1–8. Available from:

Caravaggi C, Grigoletto F, Scuderi N. Wound Bed Preparation With a Dermal Substitute (Hyalomatrix® PA) Facilitates Re-epithelialization and Healing: Results of a Multicenter, Prospective, Observational Study on Complex Chronic Ulcers (The FAST Study). Wounds [Internet]. 2011;23(8):228–35. Available from:

Michael S, Winters C, Khan M. Acellular Fish Skin Graft Use for Diabetic Lower Extremity Wound Healing: A Retrospective Study of 58 Ulcerations and a Literature Review. Wounds [Internet]. 2019;31(10):262–268. Available from:

Paige J, Kremer M, Landry J, Hatfield S, Wathieu D, Brug A, et al. Modulation of inflammation in wounds of diabetic patients treated with porcine urinary bladder matrix. Regen Med [Internet]. 2019/04/25. 2019 May;14(4):269–77. Available from:

Lullove E. Use of Ovine-based Collagen Extracellular Matrix and Gentian Violet/Methylene Blue Antibacterial Foam Dressings to Help Improve Clinical Outcomes in Lower Extremity Wounds: A Retrospective Cohort Study. Wounds [Internet]. 2017;29(4):107–14. Available from:

Cullen B, Smith R, McCulloch E, Silcock D, Morrison L. Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Repair Regen [Internet]. 2002 Jan 1;10(1):16–25. Available from:

Kelechi T, Mueller M, Hankin C, Bronstone A, Samies J, Bonham P. A randomized, investigator-blinded, controlled pilot study to evaluate the safety and efficacy of a poly-N-acetyl glucosamine–derived membrane material in patients with venous leg ulcers. J Am Acad Dermatol [Internet]. 2012;66(6):209–15. Available from:

Lee J, Kim J, Lee J, Chung K, Kim T, Kim Y, et al. Wound healing effects of paste type acellular dermal matrix subcutaneous injection. Arch Plast Surg [Internet]. 2018/11/15. 2018 Nov;45(6):504–11. Available from:

Cazzell SM, Vayser D, Pham H, Walters J, Reyzelman A, Samsell B, et al. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator. Wound Repair Regen [Internet]. 2017 May 1;25(3):483–97. Available from:

Marston W, Hanft J, Norwood P, Pollak R. The Efficacy and Safety of Dermagraft in Improving the Healing of Chronic Diabetic Foot Ulcers. Diabetes Care [Internet]. 2003 Jun 1;26(6):1701–5. Available from:

Reyzelman A, Crews R, Moore J, Moore L, Mukker J, Offutt S, et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. Int Wound J [Internet]. 2009 Jun 1;6(3):196–208. Available from:

Brigido S, Boc S, Lopez R. Effective management of major lower extremity wounds using an acellular regenerative tissue matrix: A pilot study. Orthopedics [Internet]. 2004 Jan 1 [cited 2020 Jun 26];27(1 SUPPL.):s145-9. Available from:

Brigido S. The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: A prospective 16-week pilot study. Int Wound J [Internet]. 2006 [cited 2020 Jun 26];3(3):181–7. Available from:

Cazzell S, Lange D, Dickerson J, Slade H. The Management of Diabetic Foot Ulcers with Porcine Small Intestine Submucosa Tri-Layer Matrix: A Randomized Controlled Trial. Adv Wound Care [Internet]. 2015 Dec [cited 2020 Jun 26];4(12):711–8. Available from:

Driver V, Lavery L, Reyzelman A, Dutra T, Dove C, Kotsis S, et al. A clinical trial of Integra Template for diabetic foot ulcer treatment. Wound Repair Regen [Internet]. 2015 Nov 1 [cited 2020 Jun 26];23(6):891–900. Available from:

Hu Z, Zhu J, Cao X, Chen C, Li S, Guo D, et al. Composite skin grafting with human acellular dermal matrix scaffold for treatment of diabetic foot ulcers: A randomized controlled trial. J Am Coll Surg [Internet]. 2016 Jun 1 [cited 2020 Jun 26];222(6):1171–9. Available from:

Jeon M, Kim S. Application of a paste-type acellular dermal matrix for coverage of chronic ulcerative wounds. Arch Plast Surg [Internet]. 2018 Nov 1 [cited 2020 Jun 26];45(6):564–71. Available from:

Niezgoda J, Van Gils C, Frykberg R, Hodde J. Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers. Adv Skin Wound Care [Internet]. 2005 [cited 2020 Jun 26];18(5 Pt 1):258–66. Available from:

Winters C, Brigido S, Liden B, Simmons M, Hartman J, Wright M. A multicenter study involving the use of a human acellular dermal regenerative tissue matrix for the treatment of diabetic lower extremity wounds. Adv Skin Wound Care [Internet]. 2008 Aug [cited 2020 Jun 26];21(8):375–81. Available from:

Zelen CM, Orgill DP, Serena TE, Galiano RE, Carter MJ, DiDomenico LA, et al. An aseptically processed, acellular, reticular, allogenic human dermis improves healing in diabetic foot ulcers: A prospective, randomised, controlled, multicentre follow-up trial. Int Wound J [Internet]. 2018 Oct 1 [cited 2020 Jun 26];15(5):731–9. Available from:

Harding K, Kirsner R, Lee D, Serena T. Acellular Matrices for the treatment of wounds [Internet]. Calne S, editor. London, UK: Wounds International Enterprise House; 2011. 1–16 p. Available from:

Cornwell K, Landsman A, James K. Extracellular Matrix Biomaterials for Soft Tissue Repair. Clin Podiatr Med Surg [Internet]. 2009;26(4):507–23. Available from:

Schultz G, Wysocki A. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen [Internet]. 2009 Mar 1;17(2):153–62. Available from:

Clark R, Ghosh K, Tonnesen M. Tissue Engineering for Cutaneous Wounds. J Invest Dermatol [Internet]. 2007 May 1;127(5):1018–29. Available from:

Gibson D, Cullen B, Legerstee R, Harding K, Schultz G. MMPs Made Easy. Wounds [Internet]. 2009;1(1):1–6. Available from:

Licencia de Creative Commons
Esta obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.